Pediatric and Adolescent Gynecology

Evidence-Based Clinical Practice

Editor(s): Sultan C. (Montpellier) 
Table of Contents
Vol. 22, 2012
Section title: The Prepubertal Girl
Sultan C (ed): Pediatric and Adolescent Gynecology. Evidence-Based Clinical Practice. 2nd, revised and extended edition. Endocr Dev. Basel, Karger, 2012, vol 22, pp 56–71

Disorders of Sex Development: Neonatal Diagnosis and Management

Paris F. · Gaspari L. · Philibert P. · Maïmoun L. · Kalfa N. · Sultan C.
aUnité d’Endocrinologie-Gynécologie Pédiatriques, Département de Pédiatrie, Hôpital A. de Villeneuve, bService d’Hormonologie (Développement et Reproduction), Hôpital Lapeyronie, et cService de Chirurgie Pédiatrique, Hôpital Lapeyronie, CHU Montpellier et Université Montpellier 1, Montpellier, France

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


The disorders of sex development (DSD) refer to the insufficient virilization of the external genitalia of a 46,XY fetus or the excessive virilization of those of the 46,XX fetus. Some of these disorders are associated with karyotype abnormalities. DSD arise from abnormal gonadal determination or sex differentiation, as in the case of the abnormal testosterone synthesis or androgen insensitivity of 46,XY DSD. The impact of environmental endocrine disrupting chemicals during fetal life requires further investigation. The basic investigations should include SRY gene sequencing and measurement of 17-hydroxyprogesterone, anti-Mullerian hormone, and testosterone. Choosing the sex of rearing is difficult and the decision must be made by an experienced multidisciplinary team.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Hughes IA, Houk C, Ahmed SF, Lee PA: Consensus statement on management of intersex disorders. Arch Dis Child 2006;91:554-563
  2. Balsamo A, Baldazzi L, Menabo S, Cicognani A: Impact of molecular genetics on congenital adrenal hyperplasia management. Sex Dev 2010;4:233-248
  3. Houk CP, Lee PA: Approach to assigning gender in 46, XX congenital adrenal hyperplasia with male external genitalia: replacing dogmatism with pragmatism. J Clin Endocrinol Metab 2010;95:4501-4508
  4. Nimkarn S, New MI: Steroid 11beta-hydroxylase deficiency congenital adrenal hyperplasia. Trends Endocrinol Metab 2008;19:96-99
  5. Krone N, Arlt W: Genetics of congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab 2009;23:181-192
  6. Sahakitrungruang T, Soccio RE, Lang-Muritano M, Walker JM, Achermann JC, Miller WL: Clinical, genetic, and functional characterization of four patients carrying partial loss-of-function mutations in the steroidogenic acute regulatory protein (StAR). J Clin Endocrinol Metab 2010;95:3352-3359
  7. Scott RR, Miller WL: Genetic and clinical features of p450 oxydoreductase deficiency. Horm Res 2008;69:266-275
  8. Lin L, Ercan O, Raza J, Burren CP, Creighton SM, Auchus RJ, Dattani MT, Achermann JC: Variable phenotypes associated with aromatase (CYP19) insufficiency in humans. J Clin Endocrinol Metab 2007;92:982-990
  9. Spitzer RF, Wherrett D, Chitayat D, Colgan T, Dodge JE, Salle JL, Allen L: Maternal luteoma of pregnancy presenting with virilization of the female infant. J Obstet Gynaecol Can 2007;29:835-840
  10. Hughes IA: Disorders of sex development: a new definition and classification. Best Pract Res Clin Endocrinol Metab 2008;22:119-134
  11. Parma P, Radi O: Forgetting RSPO1. Fertil Steril 2010;94:e39author replye40
  12. Cox JJ, Willatt L, Homfray T, Woods CG: A SOX9 duplication and familial 46, XX developmental testicular disorder. N Engl J Med 2011;364:91-93
  13. Refai O, Friedman A, Terry L, Jewett T, Pearlman A, Perle MA, Ostrer H: De novo 12; 17 translocation upstream of SOX9 resulting in 46, XX testicular disorder of sex development. Am J Med Genet A 2010;152A:422-426
  14. Paris F, Philibert P, Lumbroso S, Baldet P, Charvet JP, Galifer RB, Sultan C: Primary amenorrhea in a 46, XY adolescent girl with partial gonadal dysgenesis: identification of a new SRY gene mutation. Fertil Steril 2007;88:1437e21-e25
  15. Sekido R, Lovell-Badge R: Sex determination and SRY: down to a wink and a nudge?. Trends Genet 2009;25:19-29
  16. Lin L, Philibert P, Ferraz-de-Souza B, Kelberman D, Homfray T, Albanese A, Molini V, Sebire NJ, Einaudi S, Conway GS, Hughes IA, Jameson JL, Sultan C, Dattani MT, Achermann JC: Heterozygous missense mutations in steroidogenic factor 1 (SF1/ Ad4BP, NR5A1) are associated with 46, XY disorders of sex development with normal adrenal function. J Clin Endocrinol Metab 2007;92:991-999
  17. Paris F, De Ferran K, Bhangoo A, Ten S, Lahlou N, Audran F, Servant N, Poulat F, Philibert P, Sultan C: Isolated ‘idiopathic’ micropenis: hidden genetic defects?. Int J Androl 2011;doi: 10.1111/j.1365-2605. 2010.01135.x. [2011]
  18. Philibert P, Paris F, Audran F, Kalfa N, Polak M, Thibaud E, Pinto G, Houang M, Zenaty D, Leger J, Mas JC, Pienkowski C, Einaudi S, Damiani D, Ten S, Sinha S, Poulat F, Sultan C: Phenotypic variation of SF1 gene mutations. Adv Exp Med Biol 2011;707:67-72
  19. Chiang PW, Aliaga S, Travers S, Spector E, Tsai AC: Case report: WT1 exon 6 truncation mutation and ambiguous genitalia in a patient with Denys-Drash syndrome. Curr Opin Pediatr 2008;20:103-106
  20. Bache M, Dheu C, Doray B, Fothergill H, Soskin S, Paris F, Sultan C, Fischbach M: Frasier syndrome, a potential cause of end-stage renal failure in childhood. Pediatr Nephrol 2010;25:549-552
  21. Gentilin B, Forzano F, Bedeschi MF, Rizzuti T, Faravelli F, Izzi C, Lituania M, Rodriguez-Perez C, Bondioni MP, Savoldi G, Grosso E, Botta G, Viora E, Baffico AM, Lalatta F: Phenotype of five cases of prenatally diagnosed campomelic dysplasia harboring novel mutations of the SOX9 gene. Ultrasound Obstet Gynecol 2010;36:315-323
  22. Lecointre C, Pichon O, Hamel A, Heloury Y, Michel-Calemard L, Morel Y, David A, Le Caignec C: Familial acampomelic form of campomelic dysplasia caused by a 960 kb deletion upstream of SOX9. Am J Med Genet A 2009;149A:1183-1189
  23. Okamoto T, Nakamura E, Nagaya K, Hayashi T, Mukai T, Fujieda K: Patient reports: two novel frameshift mutations in the SOX9 gene in two patients with campomelic dysplasia who showed long-term survival. J Pediatr Endocrinol Metab 2011;23:1189-1193
  24. Pearlman A, Loke J, Le Caignec C, White S, Chin L, Friedman A, Warr N, Willan J, Brauer D, Farmer C, Brooks E, Oddoux C, Riley B, Shajahan S, Camerino G, Homfray T, Crosby AH, Couper J, David A, Greenfield A, Sinclair A, Ostrer H: Mutations in MAP3K1 cause 46, XY disorders of sex development and implicate a common signal transduction pathway in human testis determination. Am J Hum Genet 2010;87:898-904
  25. Barbaro M, Oscarson M, Schoumans J, Staaf J, Ivarsson SA, Wedell A: Isolated 46, XY gonadal dysgenesis in two sisters caused by a Xp21.2 interstitial duplication containing the DAX1 gene. J Clin Endocrinol Metab 2007;92:3305-3313
  26. Biason-Lauber A, Konrad D, Meyer M, DeBeaufort C, Schoenle EJ: Ovaries and female phenotype in a girl with 46, XY karyotype and mutations in the CBX2 gene. Am J Hum Genet 2009;84:658-663
  27. Miller WL, Agrawal V, Sandee D, Tee MK, Huang N, Choi JH, Morrissey K, Giacomini KM: Consequences of POR mutations and polymorphisms. Mol Cell Endocrinol 2011;336:174-179
  28. Mendonca BB, Domenice S, Arnhold IJ, Costa EM: 46, XY disorders of sex development (DSD). Clin Endocrinol (Oxf) 2009;70:173-187
  29. Werner R, Grotsch H, Hiort O: 46, XY disorders of sex development-the undermasculinised male with disorders of androgen action. Best Pract Res Clin Endocrinol Metab 2010;24:263-277
  30. Bhangoo A, Paris F, Philibert P, Audran F, Ten S, Sultan C: Isolated micropenis reveals partial androgen insensitivity syndrome confirmed by molecular analysis. Asian J Androl 2010;12:561-566
  31. Maimoun L, Philibert P, Cammas B, et al: Phenotypical, biological, and molecular heterogeneity of 5{alpha}-reductase deficiency: an extensive international experience of 55 patients. J Clin Endocrinol Metab 2011;96:296-307
  32. Matsubara K, Iwamoto H, Yoshida A, Ogata T: Semen analysis and successful paternity by intracytoplasmic sperm injection in a man with steroid 5alpha-reductase-2 deficiency. Fertil Steril 2010;94:2770e7-e10
  33. Fukami M, Wada Y, Miyabayashi K, Nishino I, Hasegawa T, Nordenskjold A, Camerino G, Kretz C, Buj-Bello A, Laporte J, Yamada G, Morohashi K, Ogata T: CXorf6 is a causative gene for hypospadias. Nat Genet 2006;38:1369-1371
  34. Kalfa N, Liu B, Klein O, Audran F, Wang MH, Mei C, Sultan C, Baskin LS: Mutations of CXorf6 are associated with a range of severities of hypospadias. Eur J Endocrinol 2008;159:453-458
  35. Boisen KA, Chellakooty M, Schmidt IM, Kai CM, Damgaard IN, Suomi AM, Toppari J, Skakkebaek NE, Main KM: Hypospadias in a cohort of 1072 Danish newborn boys: prevalence and relationship to placental weight, anthropometrical measurements at birth, and reproductive hormone levels at three months of age. J Clin Endocrinol Metab 2005;90:4041-4046
  36. Lund L, Engebjerg MC, Pedersen L, Ehrenstein V, Norgaard M, Sorensen HT: Prevalence of hypospadias in Danish boys: a longitudinal study, 1977-2005. Eur Urol 2009;55:1022-1026
  37. Cortes D, Kjellberg EM, Breddam M, Thorup J: The true incidence of cryptorchidism in Denmark. J Urol 2008;179:314-318
  38. Main KM, Skakkebaek NE, Virtanen HE, Toppari J: Genital anomalies in boys and the environment. Best Pract Res Clin Endocrinol Metab 2010;24:279-289
  39. Stoker TE, Cooper RL, Lambright CS, Wilson VS, Furr J, Gray LE: In vivo and in vitro anti-androgenic effects of DE-71, a commercial polybrominated diphenyl ether (PBDE) mixture. Toxicol Appl Pharmacol 2005;207:78-88
  40. Fernandez MF, Olmos B, Granada A, López-Espinosam MJ, Molina-Molina JM, Fernandez JM, Cruz M, Olea-Serrano F, Olea N: Human exposure to endocrine-disrupting chemicals and prenatal risk factors for cryptorchidism and hypospadias: a nested case-control study. Environ Health Perspect 2007;115:8-14
  41. Gaspari L, Paris F, Jandel C, Kalfa N, Orsini M, Daurès JP, Sultan C: Prenatal environmental risk factors for genital malformations in a population of 1442 French male newborns: a nested case-control study. Hum Reprod 2011;26:3155-3162
  42. Brucker-Davis F, Ducot B, Wagner-Mahler K, Tommasi C, Ferrari P, Pacini P, Boda-Buccino M, Bongain A, Azuar P, Fenichel P: Environmental pollutants in maternal milk and cryptorchidism. Gynecol Obstet Fertil 2008;36:840-847
  43. Christiansen S, Scholze M, Axelstad M, Boberg J, Kortenkamp A, Hass U: Combined exposure to anti-androgens causes markedly increased frequencies of hypospadias in the rat. Int J Androl 2008;31:241-248
  44. Kalfa N, Philibert P, Baskin LS, Sultan C: Hypospadias: interactions between environment and genetics. Mol Cell Endocrinol 2011;335:89-95
  45. Paris F, Jeandel C, Servant N, Sultan C: Increased serum estrogenic bioactivity in three male newborns with ambiguous genitalia: a potential consequence of prenatal exposure to environmental endocrine disruptors. Environ Res 2006;100:39-43
  46. Skakkebaek NE, Rajpert-De Meyts E, Main KM: Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 2001;16:972-978
  47. Alonso G, Pasqualini T, Busaniche J, Ruiz E, Chemes H: True hermaphroditism in a phenotypic male without ambiguous genitalia: an unusual presentation at puberty. Horm Res 2007;68:261-264
  48. Verkauskas G, Jaubert F, Lortat-Jacob S, Malan V, Thibaud E, Nihoul-Fekete C: The long-term follow-up of 33 cases of true hermaphroditism: a 40-year experience with conservative gonadal surgery. J Urol 2007;177:726-731discussion 731
  49. Mazen I, El-Ruby M, El-Bassyouni HT: Variable associations of Klinefelter syndrome in children. J Pediatr Endocrinol Metab 2010;23:985-989

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50